Higher ARB doses mean better outcomes for heart failure

11/18/2009 | USA Today

Researchers said if physicians gave heart failure patients a larger dose of angiotensin-receptor blockers, or ARBs, it would lead to fewer hospitalizations and deaths each year. A study of almost 4,000 patients given either 50 milligrams or 150 milligrams found death rates dropped 10% for those getting the higher dose.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ